What is Praxsyn Corporation (PXYN)?

Praxsyn Corporation (PXYN) is a stock in the Healthcare sector, Medical - Pharmaceuticals industry. View full analysis on Stocks360.

What is the current price of PXYN?

The current price of PXYN is $0.00. Prices are updated in real time on Stocks360.

What is PXYN's price-to-earnings (PE) ratio?

PXYN's trailing twelve-month PE ratio is -0.01, based on current price and earnings per share data available on Stocks360.

What is PXYN's market capitalization?

PXYN's market capitalization is $6,347.00, placing it in the small-cap tier.

Praxsyn Corporation (PXYN)

Stock analysis · OTC · Healthcare · Medical - Pharmaceuticals

$0.00

Market Cap

$6.35K

PE (TTM)

-0.01

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.80

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

653.39K

Praxsyn Corporation (PXYN) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $6.35K. Trailing PE -0.01. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $0.00 2026-10-26 · $0.00 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Praxsyn Corporation

Praxsyn Corporation operates as a healthcare enterprise, supplying medical professionals with specific medications and related services for their patients. The company specializes in creating non-narcotic and non-habit-forming treatments, utilizing therapeutic and preventative compounds. These come in various formats, such as transdermal creams, patches, and oral capsules, and are formulated to treat issues like pain management, erectile dysfunction, and metabolic disorders. Praxsyn's offerings are available to patients covered by California's workers' compensation program, along with those under preferred provider contracts. Established in 2005, the company was formerly known as The PAWS Pet Company, Inc. before changing its name to Praxsyn Corporation in March 2014. Its operations are based out of Las Vegas, Nevada.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.01×
P/S (TTM)	0.08×
P/B	0.00×
P/FCF (TTM)	-0.00×
EV / EBITDA	-11.85×
EV / Sales	20.24×
Earnings Yield	-7654.43%
Free Cash Flow Yield	-374745.17%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$1.65M
Revenue (TTM)	$81.38K
Net Income (TTM)	-$485.83K
Free Cash Flow (TTM)	-$23.42M
Net Debt	$1.64M
Working Capital	$2.44M
Gross Margin	29.39%
Operating Margin	-240.85%
Net Margin	-695.52%
Return on Equity	-20.21%
Return on Invested Capital	-4.71%